FirmaIQ
Org.nr 985 889 635 2005 → 2006 Year-over-year analysis

LYTIX BIOPHARMA ASA: årsregnskap 2006 vs 2005

Grew 1335% on revenue, weaker earnings

Full company analysis · All year comparisons

Summary

What changed

Comparing Årsregnskap 2006 with 2005 for LYTIX BIOPHARMA ASA. Revenue 19.9k NOK → 285.0k NOK (+1335.1%). Net result -4.20m NOK → -8.09m NOK. Equity 4.34m NOK → 15.90m NOK.

On the constructive side: revenue rose; equity strengthened; cash rose. Pressures included: operating result weakened; net result weakened.

Mixed year — gains and pressures both show up.

At a glance

Scorecard

Revenue
19.9k NOK 285.0k NOK
+1335.1%
Operating result
-4.23m NOK -8.27m NOK
-95.6%
Net result
-4.20m NOK -8.09m NOK
-92.4%
Equity
4.34m NOK 15.90m NOK
+266.4%
Cash
5.17m NOK 16.13m NOK
+212.0%
Total assets
7.07m NOK 18.55m NOK
+162.3%

What improved

  • ↑

    Revenue rose

    Operating income / revenue moved from 19.9k NOK to 285.0k NOK (+1335.1% YoY). Calculated

  • ↑

    Equity strengthened

    Book equity 4.34m NOK → 15.90m NOK (equity ratio 61.4% → 85.7%). Calculated

  • ↑

    Cash rose

    Bank deposits 5.17m NOK → 16.13m NOK (+212.0% YoY). Calculated

What deteriorated

  • ↓

    Operating result weakened

    Operating result -4.23m NOK → -8.27m NOK (op. margin -21291.6% → -2902.0%). Calculated

  • ↓

    Net result weakened

    Net result -4.20m NOK → -8.09m NOK (net margin -21170.6% → -2837.8%). Calculated